The National Institutes of Institute of Allergy and Infectious Diseases announced this week that it will halt administration of an experimental HIV vaccine in the HVTN 505 trial, after an interim data analysis found that it neither prevented new HIV infections nor lowered viral load among people who did become infected.
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-prevention/4079-nih-halts-hiv-vaccine-study-due-to-lack-of-effectiveness
http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-prevention/4079-nih-halts-hiv-vaccine-study-due-to-lack-of-effectiveness
No comments:
Post a Comment